Genetic variant linked to variation in patient reponse to blood thinner

The following is an excerpt.

The discovery of a genetic variation in some blacks that affects response to the blood thinner warfarin may improve the safety and efficacy of the drug, as the era of personalized medicine approaches.

The needed dose of warfarin for blacks with the genetic variation is significantly lower than for those without it, the researchers reported online Tuesday in The Lancet.

Read the full story here: Medicine Gets Personal: Blacks Who Carry Genetic Variant May Need Lower Doses Of Blood Thinner

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend